Vincerx Pharma (VINC)
(Delayed Data from NSDQ)
$0.65 USD
-0.03 (-4.43%)
Updated Jul 29, 2024 03:59 PM ET
After-Market: $0.64 -0.01 (-1.52%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.17 |
EPS Last Quarter | -0.34 |
Last EPS Surprise | -30.77% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.74 |
Next Year | -0.48 |
EPS (TTM) | -1.55 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.17 | -0.14 | -0.74 | -0.48 |
# of Estimates | 1 | 1 | 2 | 1 |
Most Recent Consensus | -0.17 | -0.14 | -0.85 | -0.48 |
High Estimate | -0.17 | -0.14 | -0.63 | -0.48 |
Low Estimate | -0.17 | -0.14 | -0.85 | -0.48 |
Year ago EPS | -0.52 | -0.46 | -1.89 | -0.74 |
Year over Year Growth Est. | 67.31% | 69.57% | 60.85% | 35.14% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.17 | -0.14 | -0.74 | -0.48 |
7 Days Ago | -0.17 | -0.14 | -0.74 | -0.48 |
30 Days Ago | -0.17 | -0.14 | -0.74 | -0.48 |
60 Days Ago | -0.17 | -0.14 | -0.74 | -0.48 |
90 Days Ago | -0.27 | -0.34 | -0.97 | -1.11 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.17 | -0.14 | -0.74 | -0.48 |
Zacks Consensus Estimate | -0.17 | -0.14 | -0.74 | -0.48 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.34 | -0.23 | -0.46 | -0.52 | NA |
Estimate | -0.26 | -0.42 | -0.49 | -0.65 | NA |
Difference | -0.08 | 0.19 | 0.03 | 0.13 | 0.07 |
Surprise | -30.77% | 45.24% | 6.12% | 20.00% | 10.15% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more